Acadia Healthcare Company, Inc. ACHC
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About ACHC
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Acadia Healthcare Company, Inc. is a U.S.-based behavioral healthcare provider that operates inpatient psychiatric facilities, specialty treatment centers, residential treatment programs, and outpatient behavioral health services. The company operates in the broader healthcare and behavioral health industries, with a focus on mental health disorders, substance use disorders, and co-occurring conditions. Acadia generates most of its revenue through patient services reimbursed by commercial insurers, government healthcare programs, and managed care organizations. Its operating model is centered on facility-based behavioral healthcare delivery across acute inpatient, residential, and outpatient settings.
The company was founded in 2005 and is headquartered in Franklin, Tennessee. Acadia expanded rapidly through acquisitions and facility development, becoming one of the largest standalone behavioral health providers in the United States. The company has historically differentiated itself through scale, geographic breadth, and specialization in behavioral healthcare at a time when demand for mental health and addiction treatment services has increased significantly. Public filings, including SEC filings and annual reports, indicate that Acadia has focused on expanding capacity in underserved behavioral health markets and strengthening relationships with healthcare systems and payors.
Business Operations
Acadia operates through a network of behavioral healthcare facilities primarily located across the United States, with additional operations historically present in the United Kingdom through affiliated behavioral health assets. The company’s operations include acute inpatient psychiatric hospitals, specialty treatment facilities for substance use disorders, comprehensive treatment centers focused on medication-assisted treatment, and residential treatment programs. Revenue is primarily generated through patient admissions, ongoing treatment services, outpatient care, and government- and commercially reimbursed behavioral healthcare programs.
The company controls a broad portfolio of behavioral health assets and treatment infrastructure, including hospital campuses, outpatient treatment centers, and addiction recovery facilities. Acadia has also entered into partnerships and joint ventures with healthcare systems to develop behavioral health hospitals in regions with limited psychiatric capacity. These joint ventures have been a notable component of the company’s expansion strategy. Publicly disclosed partnerships with regional health systems and hospital operators have supported new facility development and referral networks in multiple states.
Strategic Position & Investments
Acadia’s strategic direction has focused on expanding behavioral healthcare access, increasing inpatient bed capacity, and developing new facilities in high-demand markets. The company has invested in de novo hospital construction, acquisitions of behavioral health facilities, and expansion of comprehensive treatment centers addressing opioid use disorder and related addiction treatment needs. Acadia’s strategy has also emphasized strengthening relationships with commercial insurers and healthcare systems amid growing national demand for behavioral health services.
The company has completed multiple acquisitions over its operating history to broaden its behavioral healthcare footprint. Acadia has also invested in joint venture behavioral hospitals with major healthcare systems to accelerate market entry while sharing development and operational resources. Behavioral health demand trends, including rising awareness of mental health conditions and substance use disorders, have supported the company’s long-term growth positioning. Company disclosures and investor materials indicate ongoing emphasis on facility modernization, workforce expansion, and operational efficiency initiatives within the behavioral healthcare sector.
Geographic Footprint
Acadia Healthcare’s primary operations are concentrated in the United States, where it maintains facilities across numerous states and metropolitan regions. Its headquarters are located in Franklin, Tennessee, and its operational footprint includes psychiatric hospitals, residential treatment centers, and outpatient clinics throughout the country. The company’s facilities are positioned in both urban and regional markets, serving children, adolescents, adults, and senior populations.
The company has also maintained international exposure through historical operations and affiliations in the United Kingdom, although its strategic focus remains predominantly U.S.-centered. Acadia’s market presence reflects broad geographic diversification within behavioral healthcare delivery, allowing it to participate in multiple regional healthcare systems and reimbursement environments. Public disclosures indicate continued investment in expanding domestic capacity and increasing access to behavioral healthcare services in underserved regions.
Leadership & Governance
Acadia Healthcare is governed by a board of directors and executive leadership team focused on behavioral healthcare expansion, operational performance, and long-term facility growth. Leadership communications in investor presentations and public filings have emphasized increasing access to mental health services, disciplined capital allocation, and expansion through both acquisitions and new facility development. The company’s governance structure reflects standard public company oversight practices consistent with healthcare industry regulatory requirements and reporting obligations under the SEC.
Key executives include:
- Christopher L. Howard – Chief Executive Officer
- Heather Dixon – President
- David M. Duckworth – Chief Financial Officer
- Matthew Peterson – Executive Vice President, General Counsel and Secretary
- Patricia H. Garland – Executive Vice President, Operations
- Richard Clark – Chairman of the Board
Information regarding executive roles, operating structure, and governance practices has been verified through publicly available company disclosures, including SEC filings, annual reports, and investor communications. Where operational details vary across reporting periods or public sources, the most consistently reported information has been reflected.